Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6295661rdf:typepubmed:Citationlld:pubmed
pubmed-article:6295661lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0022173lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0085180lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0005052lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:6295661lifeskim:mentionsumls-concept:C0682958lld:lifeskim
pubmed-article:6295661pubmed:issue1lld:pubmed
pubmed-article:6295661pubmed:dateCreated1983-3-24lld:pubmed
pubmed-article:6295661pubmed:abstractTextThe ability of three purified forms of rat liver cytochrome P-450 to metabolically activate benzo[a]pyrene, trans-benzo-[a]pyrene-7,8-dihydrodiol, 2-aminofluorene, aflatoxin B1, dimethylnitrosamine, and a pyrolysis product of tryptophan(3-amino-1-methyl-5H-pyrido(4,3-b)indole) (Trp-P-2) to mutagenic products was examined using Salmonella typhimurium strains TA98 and G46 in a reconstituted monooxygenase system. The isozymes examined were cytochrome P-450-PB (the major phenobarbital inducible form), and the two major 3-MC inducible forms (cytochromes P-448(52) and P-448(55)). Cytochromes P-448(52) and P-448(55) preferentially metabolize 2-aminofluorene and Trp-P-2 to mutagenic products. However, only cytochrome P-448(55) metabolizes benzo[a]pyrene and its 7,8-dihydrodiol derivative to mutagenic products. Both cytochrome P-448(52) and P-448(55) metabolize aflatoxin B1 to mutagenic products at a much faster rate than cytochrome P-450-PB. Dimethylnitrosamine was not activated by any of the isozymes tested.lld:pubmed
pubmed-article:6295661pubmed:languageenglld:pubmed
pubmed-article:6295661pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:citationSubsetIMlld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6295661pubmed:statusMEDLINElld:pubmed
pubmed-article:6295661pubmed:issn0143-3334lld:pubmed
pubmed-article:6295661pubmed:authorpubmed-author:GoldsteinJ...lld:pubmed
pubmed-article:6295661pubmed:authorpubmed-author:ZeigerEElld:pubmed
pubmed-article:6295661pubmed:authorpubmed-author:RobertsonI...lld:pubmed
pubmed-article:6295661pubmed:issnTypePrintlld:pubmed
pubmed-article:6295661pubmed:volume4lld:pubmed
pubmed-article:6295661pubmed:ownerNLMlld:pubmed
pubmed-article:6295661pubmed:authorsCompleteYlld:pubmed
pubmed-article:6295661pubmed:pagination93-6lld:pubmed
pubmed-article:6295661pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:meshHeadingpubmed-meshheading:6295661-...lld:pubmed
pubmed-article:6295661pubmed:year1983lld:pubmed
pubmed-article:6295661pubmed:articleTitleSpecificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.lld:pubmed
pubmed-article:6295661pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6295661pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6295661lld:pubmed